Rhumbline Advisers Haemonetics Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Haemonetics Corp stock. As of the latest transaction made, Rhumbline Advisers holds 158,238 shares of HAE stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
158,238
Previous 161,661 2.12%
Holding current value
$11.2 Million
Previous $13.4 Million 4.91%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$72.45 - $91.58 $247,996 - $313,478
-3,423 Reduced 2.12%
158,238 $12.7 Million
Q2 2024

Aug 01, 2024
BUY
$81.24 - $97.37 $68,404 - $81,985
842 Added 0.52%
161,661 $13.4 Million
Q1 2024

May 09, 2024
BUY
$71.24 - $85.35 $52,788 - $63,244
741 Added 0.46%
160,819 $13.7 Million
Q4 2023

Feb 08, 2024
SELL
$80.59 - $92.61 $230,084 - $264,401
-2,855 Reduced 1.75%
160,078 $13.7 Million
Q3 2023

Nov 09, 2023
BUY
$82.56 - $93.49 $92,302 - $104,521
1,118 Added 0.69%
162,933 $14.6 Million
Q2 2023

Aug 08, 2023
SELL
$80.84 - $89.45 $9,215 - $10,197
-114 Reduced 0.07%
161,815 $13.8 Million
Q1 2023

May 11, 2023
SELL
$72.75 - $90.6 $118,073 - $147,043
-1,623 Reduced 0.99%
161,929 $13.4 Million
Q4 2022

Feb 14, 2023
SELL
$73.85 - $86.14 $66,834 - $77,956
-905 Reduced 0.55%
163,552 $12.9 Million
Q3 2022

Nov 10, 2022
BUY
$63.3 - $78.66 $431,769 - $536,539
6,821 Added 4.33%
164,457 $12.2 Million
Q2 2022

Aug 11, 2022
BUY
$49.27 - $66.08 $436,827 - $585,865
8,866 Added 5.96%
157,636 $10.3 Million
Q1 2022

May 12, 2022
BUY
$43.77 - $63.22 $123,300 - $178,090
2,817 Added 1.93%
148,770 $9.41 Million
Q4 2021

Feb 10, 2022
BUY
$49.55 - $74.59 $228,921 - $344,605
4,620 Added 3.27%
145,953 $7.74 Million
Q3 2021

Nov 12, 2021
BUY
$57.6 - $70.59 $62,496 - $76,590
1,085 Added 0.77%
141,333 $9.98 Million
Q2 2021

Aug 05, 2021
BUY
$51.81 - $118.56 $165,377 - $378,443
3,192 Added 2.33%
140,248 $9.35 Million
Q1 2021

May 06, 2021
SELL
$111.01 - $139.48 $203,259 - $255,387
-1,831 Reduced 1.32%
137,056 $15.2 Million
Q4 2020

Feb 10, 2021
SELL
$88.75 - $119.95 $12,425 - $16,793
-140 Reduced 0.1%
138,887 $16.5 Million
Q3 2020

Nov 12, 2020
SELL
$75.65 - $93.58 $355,101 - $439,264
-4,694 Reduced 3.27%
139,027 $12.1 Million
Q2 2020

Aug 13, 2020
SELL
$84.96 - $118.91 $769,142 - $1.08 Million
-9,053 Reduced 5.93%
143,721 $12.9 Million
Q1 2020

May 06, 2020
SELL
$74.34 - $121.82 $129,723 - $212,575
-1,745 Reduced 1.13%
152,774 $15.2 Million
Q4 2019

Feb 05, 2020
SELL
$114.37 - $129.46 $103,390 - $117,031
-904 Reduced 0.58%
154,519 $17.8 Million
Q3 2019

Oct 23, 2019
SELL
$117.16 - $138.52 $825,275 - $975,734
-7,044 Reduced 4.34%
155,423 $19.6 Million
Q2 2019

Aug 14, 2019
BUY
$81.74 - $120.34 $216,202 - $318,299
2,645 Added 1.65%
162,467 $19.6 Million
Q1 2019

May 01, 2019
BUY
$83.25 - $102.12 $18,648 - $22,874
224 Added 0.14%
159,822 $14 Million
Q4 2018

Jan 31, 2019
BUY
$90.66 - $116.63 $5.85 Million - $7.53 Million
64,530 Added 67.88%
159,598 $16 Million
Q3 2018

Nov 07, 2018
SELL
$89.96 - $114.58 $572,235 - $728,843
-6,361 Reduced 6.27%
95,068 $10.9 Million
Q2 2018

Aug 06, 2018
SELL
$71.53 - $95.75 $1.78 Million - $2.38 Million
-24,892 Reduced 19.71%
101,429 $9.1 Million
Q1 2018

May 02, 2018
BUY
$60.72 - $74.41 $210,212 - $257,607
3,462 Added 2.82%
126,321 $9.24 Million
Q4 2017

Feb 09, 2018
BUY
$44.96 - $58.99 $817,822 - $1.07 Million
18,190 Added 17.38%
122,859 $7.14 Million
Q3 2017

Nov 06, 2017
BUY
$40.38 - $44.87 $4.23 Million - $4.7 Million
104,669
104,669 $4.7 Million

Others Institutions Holding HAE

# of Institutions
330
Shares Held
53.9M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.63B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email